Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 06, 2022

SELL
$0.63 - $1.59 $74,468 - $187,944
-118,204 Closed
0 $0
Q4 2021

Feb 08, 2022

SELL
$1.27 - $2.42 $4,052 - $7,722
-3,191 Reduced 2.63%
118,204 $150,000
Q3 2021

Oct 28, 2021

BUY
$2.15 - $3.82 $2,203 - $3,915
1,025 Added 0.85%
121,395 $265,000
Q2 2021

Jul 27, 2021

BUY
$2.89 - $4.45 $32,810 - $50,520
11,353 Added 10.41%
120,370 $451,000
Q1 2021

May 03, 2021

SELL
$2.9 - $4.09 $23,637 - $33,337
-8,151 Reduced 6.96%
109,017 $355,000
Q4 2020

Feb 04, 2021

SELL
$3.38 - $5.14 $64,159 - $97,567
-18,982 Reduced 13.94%
117,168 $400,000
Q3 2020

Nov 06, 2020

BUY
$2.99 - $4.9 $135,892 - $222,700
45,449 Added 50.11%
136,150 $555,000
Q2 2020

Aug 04, 2020

SELL
$2.11 - $3.38 $11,636 - $18,640
-5,515 Reduced 5.73%
90,701 $307,000
Q1 2020

Apr 27, 2020

BUY
$1.83 - $3.45 $34,663 - $65,349
18,942 Added 24.51%
96,216 $224,000
Q4 2019

Feb 03, 2020

BUY
$3.5 - $10.35 $1,610 - $4,761
460 Added 0.6%
77,274 $281,000
Q3 2019

Oct 31, 2019

BUY
$7.03 - $9.7 $32,527 - $44,881
4,627 Added 6.41%
76,814 $637,000
Q2 2019

Aug 09, 2019

BUY
$7.36 - $11.26 $4,092 - $6,260
556 Added 0.78%
72,187 $622,000
Q1 2019

May 02, 2019

BUY
$9.08 - $11.84 $46,916 - $61,177
5,167 Added 7.77%
71,631 $766,000
Q4 2018

Feb 11, 2019

BUY
$6.39 - $16.99 $27,259 - $72,479
4,266 Added 6.86%
66,464 $582,000
Q3 2018

Oct 22, 2018

BUY
$16.52 - $24.82 $28,992 - $43,559
1,755 Added 2.9%
62,198 $1.05 Million
Q2 2018

Jul 23, 2018

BUY
$14.31 - $21.75 $6,682 - $10,157
467 Added 0.78%
60,443 $1.27 Million
Q1 2018

Apr 20, 2018

SELL
$16.09 - $23.07 $20,337 - $29,160
-1,264 Reduced 2.06%
59,976 $965,000
Q4 2017

Jan 23, 2018

BUY
$13.36 - $20.73 $76,405 - $118,554
5,719 Added 10.3%
61,240 $1.16 Million
Q3 2017

Nov 13, 2017

BUY
$8.75 - $14.07 $485,808 - $781,180
55,521
55,521 $781,000

Others Institutions Holding SPPI

# of Institutions
1
Shares Held
115K
Call Options Held
0
Put Options Held
0

About SPECTRUM PHARMACEUTICALS INC


  • Ticker SPPI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,164,000
  • Description
  • Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...
More about SPPI
Track This Portfolio

Track Texas Permanent School Fund Portfolio

Follow Texas Permanent School Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Texas Permanent School Fund, based on Form 13F filings with the SEC.

News

Stay updated on Texas Permanent School Fund with notifications on news.